Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-02

FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (USAntibiotics, LLC)

View source ↗

Summary

FDA approved a supplemental application for Amoxicillin and Clavulanate Potassium submitted by USAntibiotics, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN AND CLAVULANATE POTASSIUM (amoxicillin and clavulanate potassium)

Snippet

SUPPL AP for AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN AND CLAVULANATE POTASSIUM)